EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.21.46 | Glomerulonephritis |
390216 |
Recurrence of dense deposits in transplanted kidney: II. Serum complement and nephritic factor profiles. |
causal interaction unassigned |
1 0 |
3.4.21.46 | Glomerulonephritis, Membranoproliferative |
390216 |
Recurrence of dense deposits in transplanted kidney: II. Serum complement and nephritic factor profiles. |
causal interaction unassigned |
1 0 |
3.4.21.46 | Hereditary Complement Deficiency Diseases |
451781 |
Serum complement concentrations, nutritional status and the outcome of measles and measles pneumonia. |
causal interaction diagnostic usage unassigned |
3 1 0 |
3.4.21.46 | Measles |
451781 |
Serum complement concentrations, nutritional status and the outcome of measles and measles pneumonia. |
causal interaction diagnostic usage unassigned |
3 1 0 |
3.4.21.46 | Virus Diseases |
451781 |
Serum complement concentrations, nutritional status and the outcome of measles and measles pneumonia. |
causal interaction diagnostic usage unassigned |
3 1 0 |
3.4.21.46 | Astrocytoma |
1279432 |
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. |
causal interaction ongoing research therapeutic application unassigned |
4 2 1 0 |
3.4.21.46 | Glioblastoma |
1279432 |
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. |
causal interaction ongoing research therapeutic application unassigned |
4 2 1 0 |
3.4.21.46 | Glioma |
1279432 |
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. |
causal interaction ongoing research therapeutic application unassigned |
4 2 1 0 |
3.4.21.46 | Neoplasms |
1279432 |
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. |
causal interaction ongoing research therapeutic application unassigned |
4 2 1 0 |
3.4.21.46 | Astrocytoma |
1445220 |
Production and interferon-gamma-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG. |
therapeutic application unassigned |
2 0 |